The Creatinine Test market size is USD 1.7 Billion in 2026.
The Creatinine Test market is projected to grow at a CAGR of 20% by 2033, reaching approximately USD 6 Billion.
The Creatinine Test market growth drivers include rising prevalence of chronic kidney disease (CKD), increasing diabetic population, and growing adoption of point-of-care diagnostic testing.
North America is the dominating region for the Creatinine Test market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Sysmex Corporation are some leading industry players in the Creatinine Test market.